EAST-1 ERAP inhibitor

ERAP inhibitor · Grey Wolf Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EAST-1 ERAP inhibitor, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1) [Phase 1, Phase 2]